Mdy 25p and beyond sooooon!!!!!!!

As the trading year comes to an end, let's just have a look at the words of our leader, below are some of the things that he promised us


Operational Highlights

*Flight product to be launched in-store by Wal-Mart in the US under the
ReliOn(R) NewTekTM brand E A R L Y in 2004.(NON SPECIFIC, early)

*QuickTek blood glucose monitoring product recorded sales of #4.0 million
in its first full year through GEMCO mail-order partner.

*Sales of the Assure family of glucose monitoring products increased by
31% to #15.3 million (2002: #11.7 million). (EXCELLENT)

*Co-Marketing Agreement with Smiths Group terminated - Group currently
SEEKING recovery of a $1.95 million milestone payment due from Smiths in
relation to the Futura Safety Syringe.(A MIRACLE IF WE SEE ANY OF THIS)
* Pre-marketing clinical trials of the Futura Safety Syringe now
successfully completed and positive data received.(76% SAID THEY'D BUY IT)

* Medisys to commence INITIAL commercial launch of the Futura Safety
Syringe through its EXISTING distributors and also using its OWN sales force
in the SECOND quarter of 2004.(INITIAL)(INITIAL)(INITIAL)

*Futura Scalpel to be re-launched, also through existing distributors and
the Group's own sales force EARLY in 2004.(WE NEED THE REVENUE)

David Conn, Chief Executive Officer said: "The year under review represented a
turning point in the Group's operating performance and it is gratifying that our
efforts to increase revenues and to decrease costs have resulted in a positive
EBITDA (before exceptional items) for the first time in the history of Medisys.

"For the current year, management remains totally committed to improving the
underlying profitability of the business through increasing revenues from
currently marketed products, launching new products, in particular NewTek and
the Futura Safety Syringe, and continuing to maintain a tight control on costs."

JUST GET ON WITH IT, AS WE KNOW YOU WILL

Good Luck